Related Experiment Video
Updated: Mar 29, 2026

Super-resolution Imaging of Proteus mirabilis Biofilm by Expansion Microscopy
Published on: July 18, 2025
A lytic phage targeting virulent Proteus mirabilis for effective biofilm eradication
Wenjie Ma1, Ping Li2, Xin Zhou3
1College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University, Yangzhou, 225009, China.
Abstract:
Proteus mirabilis is an opportunistic pathogen frequently associated with catheter-associated urinary tract infections (CAUTIs), where robust crystalline biofilms contribute to chronicity, antimicrobial tolerance, and recurrence. The rising prevalence of multidrug-resistant (MDR) P. mirabilis has prompted interest in bacteriophage therapy as an alternative to conventional antibiotics. In this study, we isolated a lytic bacteriophage, vB_PmiM_ZX7, from sewage using a highly virulent clinical strain, P. mirabilis YV2, as the host. vB_PmiM_ZX7 displayed a broad host range among MDR P. mirabilis isolates and tolerance to a wide range of pH and temperatures. Genome sequencing revealed 60% of genes with unknown function, absence of virulence or antibiotic resistance genes, and limited similarity to known P. mirabilis phages, underscoring its genomic novelty. Safety evaluation in a murine model showed no adverse effect, histopathological changes, or persistent phage accumulation. Circulating phages were cleared from the blood within 5 h and from organs within 48 h. In anti-biofilm assays, vB_PmiM_ZX7 eradicated 62.2% of established biofilms, outperforming piperacillin/tazobactam (TZP), and significantly reduced extracellular polysaccharide content and biofilm density, as confirmed by scanning electron microscopy and fluorescence imaging. Furthermore, vB_PmiM_ZX7 demonstrated strong anti-biofilm activity in an in vitro catheter-associated biofilm model, markedly reducing the viability of biofilm-associated bacteria in a time-dependent manner. These findings demonstrated the potential of vB_PmiM_ZX7 as a therapeutic candidate for catheter-associated MDR P. mirabilis infections.
Insights
A novel bacteriophage, vB_PmiM_ZX7, effectively eradicated multidrug-resistant Proteus mirabilis biofilms, offering a promising alternative to antibiotics for catheter-associated urinary tract infections.
Area of Science:
- Microbiology
- Bacteriophage Therapy
- Antimicrobial Resistance
Background:
- Proteus mirabilis is a key pathogen in catheter-associated urinary tract infections (CAUTIs).
- Crystalline biofilms produced by P. mirabilis contribute to chronic infections and antibiotic tolerance.
- The rise of multidrug-resistant (MDR) P. mirabilis necessitates alternative therapeutic strategies.
Purpose of the Study:
- To isolate and characterize a novel lytic bacteriophage for targeting MDR P. mirabilis.
- To evaluate the safety and efficacy of the bacteriophage against P. mirabilis biofilms in vitro and in vivo.
Main Methods:
- Isolation of bacteriophage vB_PmiM_ZX7 from sewage using P. mirabilis YV2.
- Genome sequencing and analysis of the bacteriophage.
- In vitro anti-biofilm assays and comparison with piperacillin/tazobactam (TZP).
- In vivo safety evaluation in a murine model.
- Assessment of anti-biofilm activity in a catheter-associated biofilm model.
Main Results:
- vB_PmiM_ZX7 demonstrated a broad host range against MDR P. mirabilis isolates and stability across various pH and temperatures.
- Genome analysis revealed genomic novelty with no identified virulence or antibiotic resistance genes.
- The bacteriophage was safe in a murine model, with rapid clearance from blood and organs.
- vB_PmiM_ZX7 eradicated 62.2% of established biofilms, outperforming TZP, and reduced biofilm matrix components.
- Significant reduction in biofilm-associated bacterial viability was observed in a catheter model.
Conclusions:
- Bacteriophage vB_PmiM_ZX7 is a promising, safe therapeutic candidate against MDR P. mirabilis.
- Its potent anti-biofilm activity makes it suitable for treating CAUTIs caused by P. mirabilis.
- Phage therapy represents a viable alternative to conventional antibiotics for MDR P. mirabilis infections.
More Related Videos
Related Concept Videos
Lytic Cycle of Bacteriophages
Biological Methods for Microbial Control
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing
Viral Replication: Lytic Cycle
Lysogenic Cycle of Bacteriophages

